Stay updated with breaking news from Peter salzmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Citigroup began coverage on shares of Immunovant (NASDAQ:IMVT – Get Rating) in a research report report published on Tuesday, The Fly reports. The brokerage issued a buy rating and a $28.00 price objective on the stock. Several other brokerages also recently commented on IMVT. Cantor Fitzgerald assumed coverage on Immunovant in a research note on […] ....
Equities research analysts at Stifel Nicolaus assumed coverage on shares of Immunovant (NASDAQ:IMVT – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating on the stock. A number of other equities analysts have also recently issued reports on IMVT. SVB Leerink increased their target price […] ....
Immunovant (NASDAQ:IMVT – Get Rating) had its price target lifted by HC Wainwright from $21.00 to $26.00 in a report published on Monday morning, The Fly reports. HC Wainwright also issued estimates for Immunovant’s FY2026 earnings at ($1.19) EPS and FY2027 earnings at ($0.05) EPS. Several other equities research analysts have also recently commented on […] ....
Form 10-K Corbus Pharmaceuticals For: Dec 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
City Commissioners heard loud opposition and support Wednesday to a proposed city policy that would ban homeless camping across Portland. The seven hours of testimony, provided by more than 200 Portlanders, painted a clear picture of who stands to benefit from the plan—and who could be harmed by the ordinance as proposed. "I can tell you again and again, camping bans come up as something politicians brandish to placate some constituents while making life unbearable. ....